Press releases | UCB
UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

22 Apr 2022

Disposal of own shares

Read More
15 Apr 2022

Disposal of own shares

Read More
11 Apr 2022

Disposal of own shares

Read More
1 Apr 2022

Disposal of own shares

Read More
1 Apr 2022

UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting

Read More
28 Mar 2022

U.S. FDA Approves FINTEPLA® ▼(fenfluramine) Oral Solution for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe